I agree that this site is using cookies. You can find further informations
here
.
X
Login
Merkliste (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
zur Desktop-Version
Toggle navigation
Merkliste
1 Ergebnisse
1
INNODIA Master Protocol for the evaluation of investigation..:
Dunger, David B
;
Bruggraber, Sylvaine FA
;
Mander, Adrian P
...
https://www.repository.cam.ac.uk/handle/1810/338230. , 2022
Link:
https://www.repository.cam.ac.uk/handle/1810/338230
RT Journal T1
INNODIA Master Protocol for the evaluation of investigational medicinal products in children, adolescents and adults with newly diagnosed type 1 diabetes
UL https://suche.suub.uni-bremen.de/peid=base-ftunivcam:oai:www.repository.cam.ac.uk:1810_338230&Exemplar=1&LAN=DE A1 Dunger, David B A1 Bruggraber, Sylvaine FA A1 Mander, Adrian P A1 Marcovecchio, M Loredana A1 Tree, Timothy A1 Chmura, Piotr Jaroslaw A1 Knip, Mikael A1 Schulte, Anke M A1 Mathieu, Chantal A1 INNODIA consortium PB Springer Science and Business Media LLC; http://dx.doi.org/10.1186/s13063-022-06259-z; Trials YR 2022 K1 Beta-cell function K1 C-peptide K1 Master protocol K1 Phase 2 K1 Prevention K1 Trials K1 Type 1 diabetes K1 Adolescent K1 Adult K1 Biomarkers K1 COVID-19 K1 Child K1 Diabetes Mellitus K1 Type 1 K1 Humans K1 SARS-CoV-2 K1 Treatment Outcome JF https://www.repository.cam.ac.uk/handle/1810/338230 LK http://dx.doi.org/https://www.repository.cam.ac.uk/handle/1810/338230 DO https://www.repository.cam.ac.uk/handle/1810/338230 SF ELIB - SuUB Bremen
Export
RefWorks (nur Desktop-Version!)
Flow
(Zuerst in
Flow
einloggen, dann importieren)